Staff Reporter (Health Care, Law)
Sherman Oaks biopharmaceutical company T-Cure Bioscience has entered into a license agreement with Chinese biotech Immunotech Biopharm Ltd. to develop a T cell therapy for renal cancer.
California State University – Northridge will become a large-scale COVID-19 vaccination site.
Bed capacity and staffing in the red, mortuaries full.
Hospitals in the Valley are seeing surges linked to holiday gatherings, staff said, threatening to overwhelm plans put in place at the beginning of the pandemic to accommodate a massive influx of patients.
Universal Diagnostic tries direct-to-consumer strategy.
Universal Diagnostic Laboratories in Van Nuys has drastically changed its business model in the wake of COVID-19 testing.
Valley Economic Alliance holds event virtually for first time.
Valley Economic Alliance held its “Valley of the Stars ... Rising” event for the first time virtually on Jan. 15.
LIST: Administrators report full enrollment even with remote-only instruction.
So far in the coronavirus pandemic, private high schools in the Valley region have not experienced a drop in enrollment, nor have they had to reduce tuition, staffers told the Business Journal.
Health Care: Lancaster to host state’s first center for mental health plus rehab.
Lancaster will host the state’s first behavioral health and rehabilitation hospital, created by a joint venture between Antelope Valley Hospital and Kentucky-based Kindred Healthcare.
Santa Clarita tech company BioSolar Inc. has officially changed its corporate name to NewHydrogen Inc.
Amgen Inc. and EVOQ Therapeutics on Wednesday announced they have entered into a license and collaboration agreement to develop drugs for autoimmune disorders.
The City of Lancaster, in partnership with North Carolina nonprofit Samaritan’s Purse and Antelope Valley Hospital, is building a 50-bed field hospital to serve the overwhelming number of COVID-19 patients.